Fredun Pharmaceuticals Limited has disclosed that its equity shares have been permitted to trade and admitted to dealings on the National Stock Exchange of India Limited (NSE) effective August 17, 2026. This permission was granted pursuant to NSE Circular Ref. No. 1355/2026 dated August 14, 2026, issued under Regulation 3.1.1 of the National Stock Exchange (Capital Market) Trading Regulations, Part A.
The disclosure is made pursuant to Regulation 30 and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Trading Details on NSE
- NSE Symbol: FREDUN
- Date of commencement of trading on NSE: August 17, 2026
- Face Value: Rs. 10/-
- Nature of securities: Equity
The company noted that it is already listed on BSE Limited and, with this NSE circular, its equity shares are now permitted to trade on both exchanges.
The disclosure was signed by Fredun Nariman Medhora, Managing Director (DIN: 01745348), and addressed to BSE Ltd.'s Listing Department.